Deregulation of COMMD1 Is Associated with Poor Prognosis in Diffuse Large B-cell Lymphoma

Show full item record



Permalink

http://hdl.handle.net/10138/160618

Citation

Taskinen , M , Louhimo , R , Koivula , S , Chen , P , Rantanen , V , Holte , H , Delabie , J , Karjalainen-Lindsberg , M-L , Bjorkholm , M , Fluge , O , Pedersen , L M , Fjorden , K , Jerkeman , M , Eriksson , M , Hautaniemi , S & Leppä , S 2014 , ' Deregulation of COMMD1 Is Associated with Poor Prognosis in Diffuse Large B-cell Lymphoma ' , PLoS One , vol. 9 , no. 3 , 91031 . https://doi.org/10.1371/journal.pone.0091031

Title: Deregulation of COMMD1 Is Associated with Poor Prognosis in Diffuse Large B-cell Lymphoma
Author: Taskinen, Minna; Louhimo, Riku; Koivula, Satu; Chen, Ping; Rantanen, Ville; Holte, Harald; Delabie, Jan; Karjalainen-Lindsberg, Marja-Liisa; Bjorkholm, Magnus; Fluge, Oystein; Pedersen, Lars Moller; Fjorden, Karin; Jerkeman, Mats; Eriksson, Mikael; Hautaniemi, Sampsa; Leppä, Sirpa
Contributor: University of Helsinki, Research Programs Unit
University of Helsinki, Research Programs Unit
University of Helsinki, Department of Oncology
University of Helsinki, Research Programs Unit
University of Helsinki, Research Programs Unit
University of Helsinki, Haartman Institute (-2014)
University of Helsinki, Genome-Scale Biology (GSB) Research Program
University of Helsinki, Clinicum
Date: 2014-03-13
Language: eng
Number of pages: 11
Belongs to series: PLoS One
ISSN: 1932-6203
URI: http://hdl.handle.net/10138/160618
Subject: COMPARATIVE GENOMIC HYBRIDIZATION
CHEMOTHERAPY PLUS RITUXIMAB
RANDOMIZED CONTROLLED-TRIAL
AGGRESSIVE LYMPHOMAS
DISTINCT SUBGROUPS
CHOP CHEMOTHERAPY
HODGKIN-LYMPHOMA
ELDERLY-PATIENTS
YOUNG-PATIENTS
EXPRESSION
3122 Cancers
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
journal.pone.0091031.PDF 1010.Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record